Yep, still a niche market for high-risk, compounded, liquid meds. No one is going to get rich even if they sell a few, especially with the exhorbitant CDEx salaries.
For a tiny start-up company operating on a shoestring from a small shop and paying out salaries like 350K/year for Brumfield is beyond outrageous.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.